CTOs on the Move


 
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

MSI raised $30M on 10/07/2016

Similar Companies

Evans Analytical Group LLC

Evans Analytical Group (EAG) has been a global leader in surface analysis and materials characterization for over 29 years, delivering innovative analytical services and solutions with uncompromising scientific integrity.

Sierra Nevada Children's Services

Sierra Nevada Children's Services is a Grass Valley, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Persante Health Care

Persante Health Care is a national provider of sleep and balance center management services to hospitals, physician practices and patients. Persante`s expertise in sleep and balance related disorders dates back almost 20 years under the names of Sleep Care Centers, Sleep Tech, Mid-Atlantic School of Sleep Medicine and Blackwood Medical. The merging of these four unique industry leaders revolutionized the out-sourced delivery model of sleep and balance diagnosis and therapeutic treatment. This comprehensive approach to serving our client`s patients in a high quality manner has earned recognition and accreditation from The American Academy of Sleep Medicine and The National Sleep Foundation.

Eleme Medical

Eleme Medical is a Merrimack, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Central Peninsula Hospital

Central Peninsula Hospital, Inc., an acute care hospital, provides patient and resident centered care services serving the Central Peninsula area. It offers emergency care, anesthesia, emergency medicine, family medicine, ENT, general surgery, internal medicine, neurology, OB/GYN, ophthalmology, orthopedics, pathology, pediatrics, podiatry, psychiatry, and radiology services; and behavioral health services that include depression screenings, substance abuse treatment, and substance abuse treatment services. The company also provides imaging services that include diagnostic imaging, digital mammography examinations, computer axial tomography procedures, ultrasound/sonography, nuclear medicine, and magnetic resonance imaging; physical, occupational, speech, and massage therapy services; outpatient weight loss, walking and exercise programs, cardiac rehabilitation, and diabetes management services; and diabetes education services. In addition, it offers family birth center services; laboratory services that include chemistry, hematology, transfusion medicine, serology, urinalysis, microbiology, and molecular biology testing; various treatments to outpatients include chemotherapy, blood transfusions, platelet transfusions, IV antibiotics, and hydration and electrolyte replacement; and sleep center services. Central Peninsula Hospital, Inc. was formerly known as Central Peninsula General Hospital, Inc. The company was founded in 1971 and is based in Soldotna, Alaska with practices in Kenai and Soldotna, Alaska.